BE899940A - Derives n-imidazolyliques de composes bicycliques et procedes pour les preparer. - Google Patents

Derives n-imidazolyliques de composes bicycliques et procedes pour les preparer.

Info

Publication number
BE899940A
BE899940A BE0/213161A BE213161A BE899940A BE 899940 A BE899940 A BE 899940A BE 0/213161 A BE0/213161 A BE 0/213161A BE 213161 A BE213161 A BE 213161A BE 899940 A BE899940 A BE 899940A
Authority
BE
Belgium
Prior art keywords
preparing
methods
same
compounds
bicyclic compounds
Prior art date
Application number
BE0/213161A
Other languages
English (en)
Inventor
P Cozzi
G Carganico
A Pillan
U Branzoli
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of BE899940A publication Critical patent/BE899940A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention a plus particulièrement pour objet des dérivés N-imidazolyliques de composés bicycliques, plus particulièrement des dérivés du 3,4-dihydro-2H-1-benzopyrane, du 2H-1-benzopyrane, du 1,2,3,4,tétrahydronaphtalène, du 1,2-dihydronaphtalène, du naphtalène, de l'indane et de l'indène, ainsi qu'un procédé de préparation de ces composés et les compositions pharmaceutiques qui les contiennent. Les composés en question conviennent au traitement de troubles circulatoires, de la microangiopathie diabétique, à titre d'agents anti-hypertension, pour le traitement de l'angine de poitrine, etc.
BE0/213161A 1983-06-20 1984-06-18 Derives n-imidazolyliques de composes bicycliques et procedes pour les preparer. BE899940A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838316744A GB8316744D0 (en) 1983-06-20 1983-06-20 N-imidazolyl derivatives of bicyclic compounds

Publications (1)

Publication Number Publication Date
BE899940A true BE899940A (fr) 1984-12-18

Family

ID=10544506

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213161A BE899940A (fr) 1983-06-20 1984-06-18 Derives n-imidazolyliques de composes bicycliques et procedes pour les preparer.

Country Status (4)

Country Link
JP (1) JPS6016975A (fr)
BE (1) BE899940A (fr)
DE (1) DE3420592A1 (fr)
GB (1) GB8316744D0 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2644593B2 (ja) * 1989-09-14 1997-08-25 キヤノン株式会社 弾性回転体及び定着装置
GB9102862D0 (en) * 1991-02-11 1991-03-27 Erba Carlo Spa N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans
US9271963B2 (en) 2005-03-03 2016-03-01 Universitat Des Saarlandes Selective inhibitors of human corticosteroid synthases

Also Published As

Publication number Publication date
GB8316744D0 (en) 1983-07-20
DE3420592A1 (de) 1984-12-20
JPS6016975A (ja) 1985-01-28

Similar Documents

Publication Publication Date Title
BE899691A (fr) Preparation medicamenteuse solide a deux phases et son procede d'obtention.
FR2436140A1 (fr) Derives de 1 a-hydroxy cyclovitamines du groupe d et leur preparation
MA27121A1 (fr) Derives 2-(purin-9-yl)-tetrahydrofuran-3,4-diol
BR9810991A (pt) Novos compostos
DZ593A1 (fr) Résinate d'un acide carboxylique substitué, procédé pour sa préparation, son utilisation et compositions pharmaceutiques le contenant.
CA2175643A1 (fr) Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique
IL85342A (en) 3-aminomethyl- dihydrobenzofuran - dihydrobenzothiophene and -indoline derivatives and 1-aminomethyl-indane derivatives, process for their preparation and pharmaceutical compositions containing them
FR2440371A1 (fr) Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
FR2426681A1 (fr) Derives d'hydantoine, procede pour leur preparation et application de ces composes comme medicaments
BE900979A (fr) 1,25-dihydroxyvitamines d2 et procedes pour les preparer.
EP0274928A3 (fr) Utilisation d'inhibiteurs de xanthine-oxydase pour la fabrication d'une composition pharmaceutique destinée au traitement du glaucome et compositions pharmaceutiques destinées au traitement du glaucome
BE899940A (fr) Derives n-imidazolyliques de composes bicycliques et procedes pour les preparer.
MC1525A1 (fr) Preparation d'une composition pour le traitement de la seborrhee
BE901603A (fr) Isomeres de l'hydroxyvitamine d2.
EP0138720A3 (fr) Nouveaux benzenesulfonamides n-cyclises, leur procédé de préparation et leur utilisation comme substance active de compositions pharmaceutiques
BE1002428A3 (fr) Compositions pharmaceutiques agissant sur le coeur et le systeme cardiovasculaire et procede pour leur preparation.
BE901889A (fr) Nouveaux polyethers glycosyles leur procede de preparation et leur utilisation.
BE899612A (fr) Derives 1 alpha, 25-dihydroxiles de la vitamine d2 et produits intermediaires pour leur preparation et compositions pharmaceutiques renfermant ces derives.
OA09446A (fr) "Dérivés di-substitués des N, N-ditriméthoxybenzoyle pipérazines, un procédé pour leur préparation et compositions thérapeutiques en contenant".
BE893492A (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques prepares avec ces esters
CA2312021A1 (fr) Utilisation des ketolides pour prevenir les complications thrombotiques arterielles liees a l'atherosclerose
FR2376863A1 (fr) Determination du 1a,25-dihydroxycholecalciferol
BE900780A (fr) DERIVES DE LA CHLORO-4-FURO (3,4-c)-PYRIDINE, LEUR PROCEDE DE PREPARATION ET COMPOSITIONS THERAPEUTIQUES A BASE DE CES DERIVES.
BE1002624A5 (fr) Compositions pour le traitement de phlebectasies et leur procede de preparation.
FR2396758A1 (fr) Nouveaux 2-thioethers d'ergoline et leurs sulfoxydes, utiles notamment comme bloqueurs des centres adrenergiques a et leurs procedes de preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FARMITALIA CARLO ERBA S.R.L.

Effective date: 19920630